載入...
Combination Therapies in Advanced, Hormone Receptor–Positive Breast Cancer
About 17% of women with breast cancer have locally advanced or metastatic disease at the time of diagnosis, and 30% to 40% of women diagnosed with early-stage disease will eventually have recurrence. The majority of breast cancers express estrogen or progesterone receptors, and hormonal therapies (H...
Na minha lista:
| 發表在: | J Adv Pract Oncol |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Harborside Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6296414/ https://ncbi.nlm.nih.gov/pubmed/30564467 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|